Moderator Daniel Ontaneda, from the Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research, is joined by Enrique Alvarez, from the University of Colorado School of Medicine, and Gabrielle Macaron, from the Université de Montréal in Quebec.